KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) EBT Margin (2016 - 2025)

Amgen (AMGN) has 17 years of EBT Margin data on record, last reported at 15.35% in Q4 2025.

  • For Q4 2025, EBT Margin rose 674.0% year-over-year to 15.35%; the TTM value through Dec 2025 reached 24.42%, up 1063.0%, while the annual FY2025 figure was 24.42%, 1063.0% up from the prior year.
  • EBT Margin reached 15.35% in Q4 2025 per AMGN's latest filing, down from 41.03% in the prior quarter.
  • Across five years, EBT Margin topped out at 56.38% in Q1 2023 and bottomed at 0.91% in Q1 2024.
  • Average EBT Margin over 5 years is 24.21%, with a median of 24.89% recorded in 2022.
  • Peak YoY movement for EBT Margin: surged 2953bps in 2023, then crashed -5729bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 31.13% in 2021, then fell by -18bps to 25.56% in 2022, then plummeted by -59bps to 10.4% in 2023, then decreased by -17bps to 8.61% in 2024, then soared by 78bps to 15.35% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 15.35% in Q4 2025, 41.03% in Q3 2025, and 17.08% in Q2 2025.